HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (12) Citing Articles via Google Scholar Google Scholar Articles by Abel, E. D. Articles by Sweeney, G. Search for Related Content PubMed PubMed Citation Articles by Abel, E. D. Articles by Sweeney, G.

Cardiac Remodeling in Obesity

Department of Biology, York University, Toronto, Canada; and Division of Endocrinology, Metabolism, and Diabetes, and Program in Human Molecular Biology and Genetics, University of Utah School of Medicine and the Salt Lake City Veterans Affairs Medical Center, Salt Lake City, Utah

The dramatic increase in the prevalence of obesity and its strong association with cardiovascular disease have resulted in unprecedented interest in understanding the effects of obesity on the cardiovascular system. A consistent, but puzzling clinical observation is that obesity confers an increased susceptibility to the development of cardiac disease, while at the same time affording protection against subsequent mortality (termed the obesity paradox). In this review we focus on evidence available from human and animal model studies and summarize the ways in which obesity can influence structure and function of the heart. We also review current hypotheses regarding mechanisms linking obesity and various aspects of cardiac remodeling. There is currently great interest in the role of adipokines, factors secreted from adipose tissue, and their role in the numerous cardiovascular complications of obesity. Here we focus on the role of leptin and the emerging promise of adiponectin as a cardioprotective agent. The challenge of understanding the association between obesity and heart failure is complicated by the multifaceted interplay between various hemodynamic, metabolic, and other physiological factors that ultimately impact the myocardium. Furthermore, the end result of obesity-associated changes in the myocardial structure and function may vary at distinct stages in the progression of remodeling, may depend on the individual pathophysiology of heart failure, and may even remain undetected for decades before clinical manifestation. Here we summarize our current knowledge of this complex yet intriguing topic.

This article has been cited by other articles:

				Y. Wang, Y. Zheng, P. M Nishina, and J. K Naggert A new mouse model of metabolic syndrome and associated complications J. Endocrinol., July 1, 2009; 202(1): 17 - 28. [Abstract] [Full Text] [PDF]

				L. L. Y. Chan, S. P. Sebert, M. A. Hyatt, T. Stephenson, H. Budge, M. E. Symonds, and D. S. Gardner Effect of maternal nutrient restriction from early to midgestation on cardiac function and metabolism after adolescent-onset obesity Am J Physiol Regulatory Integrative Comp Physiol, May 1, 2009; 296(5): R1455 - R1463. [Abstract] [Full Text] [PDF]

				J. J. Wright, J. Kim, J. Buchanan, S. Boudina, S. Sena, K. Bakirtzi, O. Ilkun, H. A. Theobald, R. C. Cooksey, K. V. Kandror, et al. Mechanisms for increased myocardial fatty acid utilization following short-term high-fat feeding Cardiovasc Res, May 1, 2009; 82(2): 351 - 360. [Abstract] [Full Text] [PDF]

				S. Boudina, H. Bugger, S. Sena, B. T. O'Neill, V. G. Zaha, O. Ilkun, J. J. Wright, P. K. Mazumder, E. Palfreyman, T. J. Tidwell, et al. Contribution of Impaired Myocardial Insulin Signaling to Mitochondrial Dysfunction and Oxidative Stress in the Heart Circulation, March 10, 2009; 119(9): 1272 - 1283. [Abstract] [Full Text] [PDF]

				R. Palanivel, V. Vu, M. Park, X. Fang, and G. Sweeney Differential impact of adipokines derived from primary adipocytes of wild-type versus streptozotocin-induced diabetic rats on glucose and fatty acid metabolism in cardiomyocytes J. Endocrinol., December 1, 2008; 199(3): 389 - 397. [Abstract] [Full Text] [PDF]

				C. X. Fang, F. Dong, D. P. Thomas, H. Ma, L. He, and J. Ren Hypertrophic cardiomyopathy in high-fat diet-induced obesity: role of suppression of forkhead transcription factor and atrophy gene transcription Am J Physiol Heart Circ Physiol, September 1, 2008; 295(3): H1206 - H1215. [Abstract] [Full Text] [PDF]

				R. Harmancey, C. R. Wilson, and H. Taegtmeyer Adaptation and Maladaptation of the Heart in Obesity Hypertension, August 1, 2008; 52(2): 181 - 187. [Full Text] [PDF]